Reset Pharma
A privately held company
Reset Pharma is developing novel, innovative treatments to restore the quality of life to patients with life-threatening cancer experiencing clinically relevant demoralization, anxiety and depression. Our lead program uses psilocybin, a promising novel treatment, to provide both rapid, and long-lasting relief in these patients. To accelerate our lead program, Reset Pharma has acquired an exclusive worldwide license from NYU Langone...